TABLE 1.
Drug category | Drug | Associated HLA locus | Odds ratio (OR) | Ethnicity | References |
---|---|---|---|---|---|
Antiseizure | Carbamazepine | HLA-B*15:02 | 2504 | Taiwan Han Chinese | Chung et al. (2004) |
1357 | Taiwan Han Chinese | Hung et al. (2006) | |||
25.5 | Thai | Locharernkul et al. (2008) | |||
54.76 | Thai | Tassaneeyakul et al. (2010) | |||
9.54 | Thai | Sukasem et al. (2018a) | |||
71.4 | Indian | Mehta et al. (2009) | |||
16.15 | Malaysian | Chang et al. (2011) | |||
184 | Central Chinese | Wu et al. (2010) | |||
114.826 | Southern Han Chinese | Wang et al. (2011) | |||
152 | Central and northern Han Chinese | Zhang et al. (2011) | |||
89.25 | Hong Kong Han Chinese | Cheung et al. (2013) | |||
6.5 | Indonesian | Yuliwulandari et al. (2017) | |||
HLA-A*31:01 | 25.93 | European | McCormack et al. (2011) | ||
7.3 | Korean | Kim et al. (2011) | |||
33.9 | Japanese | Ozeki et al. (2011) | |||
HLA-B*15:11 | 18.0 | Korean | Kim et al. (2011) | ||
9.76 | Japanese | Kaniwa et al. (2010) | |||
54.12 | Thai | Jaruthamsophon et al. (2017) | |||
HLA-B*15:21 | 40.73 | Thai | Jaruthamsophon et al. (2017) | ||
7.53 | Filipino | Capule et al. (2020) | |||
HLA-B*11:01 | 63.89 | Spanish Caucasian | Ramirez et al. (2017) | ||
Phenytoin | HLA-B*15:02 | 5.1 | Taiwan Han Chinese | Hung et al. (2010) | |
3.50 | Hong Kong Han Chinese | Cheung et al. (2013) | |||
18.5 | Thai | Locharernkul et al. (2008) | |||
5.71 | Malaysian | Chang et al. (2017) | |||
HLA-B*15:13 | 11.28 | Malaysian | Chang et al. (2017) | ||
HLA-B*56:02 | 10.40 | Thai | Tassaneeyakul et al. (2016) | ||
HLA-B*38:02 | 12.67 | Thai | Manuyakorn et al. (2020) | ||
HLA-A*02:01/Cw*15:02 | 14.75 | Spanish Caucasian | Ramirez et al. (2017) | ||
HLA-B*46:01 | 2.341 | Thai | Sukasem et al. (2020b) | ||
Lamotrigine | HLA-B*15:02 | 5.1 | Taiwan Han Chinese | Hung et al. (2010) | |
4.89 | Thai | Koomdee et al. (2017) | |||
HLA-B*15:02 | 3.59 | Hong Kong Han Chinese | Cheung et al. (2013) | ||
HLA-A*31:01 | 11.43 | Korean | Kim et al. (2017) | ||
HLA-A*02:07 | 7.83 | Thai | Koomdee et al. (2017) | ||
HLA-B*38:01 | 147 | Spanish Caucasian | Ramirez et al. (2017) | ||
Phenobarbital | HLA-A*01:01 | 11.66 | Thai | Manuyakorn et al. (2016) | |
HLA-B*13:01 | 4.60 | Thai | Manuyakorn et al. (2016) | ||
Oxcarbazepine | HLA-B*15:02 | 80.7 | Taiwan Han Chinese | Hung et al. (2010) | |
27.90 | Taiwan Han Chinese and Thai | Chen et al. (2017) | |||
Antihyperuricemia | Allopurinol | HLA-B*58:01 | 580.3 | Taiwan Han Chinese | Hung et al. (2005) |
40.83 | Japanese | Kaniwa et al. (2008) | |||
97.8 | Korean | Kang et al. (2011) | |||
80 | 89% of European Caucasian | Lonjou et al. (2008) | |||
348.3 | Thai | Tassaneeyakul et al. (2009) | |||
229.7 | Hong Kong Han Chinese | Chiu et al. (2012) | |||
203.40 | Mainland Han Chinese | Cao et al. (2012) | |||
127.60 | Mainland Han Chinese | Cheng et al. (2015a) | |||
579.0 | Thai | Sukasem et al. (2016) | |||
Decreasing intraocular pressure | Methazolamide | HLA-B*59:01 | 249.8 | Korean | Kim et al. (2010) |
305 | Mainland Han Chinese | Yang et al. (2016) | |||
HLA-Cw*01:02 | 22.1 | Korean | Kim et al. (2010) | ||
12.1 | Mainland Han Chinese | Yang et al. (2016) |